ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine

ClinicalTrials.gov ID: NCT04406649

Public ClinicalTrials.gov record NCT04406649. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine

Study identification

NCT ID
NCT04406649
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Satsuma Pharmaceuticals, Inc.
Industry
Enrollment
482 participants

Conditions and interventions

Interventions

  • Dihydroergotamine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 13, 2020
Primary completion
Jan 15, 2023
Completion
Jan 15, 2023
Last update posted
Jul 2, 2023

2020 – 2023

United States locations

U.S. sites
44
U.S. states
21
U.S. cities
43
Facility City State ZIP Site status
WR-PRI Encino California 91316
Collaborative Neuroscience Long Beach California 90806
WR-PRI Los Alamitos California 90720
Downtown LA Research Los Angeles California 90017
Clinical Research Institute Los Angeles California 90048
WR-PRI Newport Beach California 92660
Hillcrest Medical Research DeLand Florida 32720
MD Clinical Hallandale Florida 33009
Multi-Specialty Research Associates Lake City Florida 32055
ClinCloud Maitland Florida 32751
Biotech Pharmaceuticals Miami Florida 33155
Behavioral Clinical Research Miami Lakes Florida 33061
CNS Health Care - Orlando Orlando Florida 32801
Complete Health Research Ormond Beach Florida 32174
Infinity Clinical Research Sunrise Florida 33351
Santos Research Center, Corp Tampa Florida 33615
Palm Beach Research Center West Palm Beach Florida 33409
Clinical Research CF Winter Haven Florida 33880
Advanced Clinical Research Meridian Idaho 83642
Integrated Clinical Trial Services, Inc West Des Moines Iowa 50265
Delricht Research Prairieville Louisiana 70769
Medvadis Research at Boston PainCare Center Waltham Massachusetts 02451
Healthcare Research Network Hazelwood Missouri 63042
Clinvest Research Springfield Missouri 65810
Montana Medical Research Missoula Montana 59808
Wake Research - Clinical Research Center of Nevada Las Vegas Nevada 89118
Dartmouth-Hitchcock Neurology Headache Clinic Lebanon New Hampshire 03766
Hassman Research Institute Berlin New Jersey 08009
Albuquerque Clinical Trials Albuquerque New Mexico 87102
SPRI Clinical Research Brooklyn New York 11235
Montefiore Medical Center The Bronx New York 10461
PharmQuest Greensboro North Carolina 27408
PMG Research of Wilmington Wilmington North Carolina 28401
CTI Clinical Research Center Cincinnati Ohio 45212
Rapid Medical Research Cleveland Ohio 44122
Neurology Diagnosis Dayton Ohio 45459
Delricht Research Tulsa Oklahoma 74133
Thomas Jefferson University/Jefferson Headache Center Philadelphia Pennsylvania 19107
Omega Medical Research Warwick Rhode Island 02886
CNS Healthcare - Memphis Memphis Tennessee 38119
FutureSearch Trials of Neurology Austin Texas 78731
DM Clinical Research Tomball Texas 77375
Charlottesville Medical Research Charlottesville Virginia 22911
Georgetown University Hospital, Department of Neurology McLean Virginia 22101

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04406649, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04406649 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →